Cargando…

Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies

Accurate prediction of drug-drug interactions (DDI) is a challenging task in drug discovery and development. It requires determination of enzyme inhibition in vitro which is highly system-dependent for many compounds. The aim of this study was to investigate whether the determination of intracellula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Treyer, Andrea, Ullah, Mohammed, Parrott, Neil, Molitor, Birgit, Fowler, Stephen, Artursson, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581936/ https://www.ncbi.nlm.nih.gov/pubmed/31214810 http://dx.doi.org/10.1208/s12248-019-0344-8

Ejemplares similares

Intracellular drug bioavailability: a new predictor of system dependent drug disposition
por: Mateus, André, et al.
Publicado: (2017)

Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations
por: Filppula, Anne M., et al.
Publicado: (2019)

A Cell-Free Approach Based on Phospholipid Characterization for Determination of the Cell Specific Unbound Drug Fraction (f(u,cell))
por: Treyer, Andrea, et al.
Publicado: (2019)

Progress in Prediction and Interpretation of Clinically Relevant Metabolic Drug-Drug Interactions: a Minireview Illustrating Recent Developments and Current Opportunities
por: Fowler, Stephen, et al.
Publicado: (2017)

In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions
por: Karlgren, Maria, et al.
Publicado: (2011)

Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
por: Wegler, Christine, et al.
Publicado: (2021)

Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions
por: Karlgren, Maria, et al.
Publicado: (2012)

A High-Throughput Cell-Based Method to Predict the Unbound Drug Fraction in the Brain
por: Mateus, André, et al.
Publicado: (2014)

Modeling Host-Pathogen Interaction to Elucidate the Metabolic Drug Response of Intracellular Mycobacterium tuberculosis
por: Rienksma, Rienk A., et al.
Publicado: (2019)

Early Identification of Clinically Relevant Drug Interactions With the Human Bile Salt Export Pump (BSEP/ABCB11)
por: Pedersen, Jenny M., et al.
Publicado: (2013)

Acamprosate Is a Substrate of the Human Organic Anion Transporter (OAT) 1 without OAT3 Inhibitory Properties: Implications for Renal Acamprosate Secretion and Drug–Drug Interactions
por: Antonescu, Irina E., et al.
Publicado: (2020)

The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy
por: Marin, Jose JG, et al.
Publicado: (2014)

Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring
por: Englund, Gunilla, et al.
Publicado: (2004)

Intracellular Antibodies for Drug Discovery and as Drugs of the Future
por: Rabbitts, T. H.
Publicado: (2023)

Gold Nanoparticles Perturb Drug-Metabolizing Enzymes and Antioxidants in the Livers of Male Rats: Potential Impact on Drug Interactions
por: Al-Hamadani, Mohammed Y I, et al.
Publicado: (2020)

Metabolism, Transport and Drug–Drug Interactions of Silymarin
por: Xie, Ying, et al.
Publicado: (2019)

Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates
por: Kalim, Muhammad, et al.
Publicado: (2017)

In vitro and clinical investigations to determine the drug-drug interaction potential of entrectinib, a small molecule inhibitor of neurotrophic tyrosine receptor kinase (NTRK)
por: Meneses-Lorente, Georgina, et al.
Publicado: (2021)

Recommendations for the Design of Clinical Drug–Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically‐Based Pharmacokinetic Model
por: Chen, Yuan, et al.
Publicado: (2019)

Volume of Distribution is Unaffected by Metabolic Drug–Drug Interactions
por: Sodhi, Jasleen K., et al.
Publicado: (2020)

Hydrocodone, Oxycodone, and Morphine Metabolism and Drug–Drug Interactions
por: Coates, Shelby, et al.
Publicado: (2023)

Flucloxacillin/isavuconazole/voriconazole interaction: Decrease in drug concentration following drug-drug interaction and lack of efficacy: 2 case reports
Publicado: (2022)

Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative
por: Bahar, Muh. Akbar, et al.
Publicado: (2020)

Investigating the Contribution of Drug-Metabolizing Enzymes in Drug-Drug Interactions of Dapivirine and Miconazole
por: Valicherla, Guru Raghavendra, et al.
Publicado: (2021)

Intracellular Protein–Drug Interactions Probed by Direct Mass Spectrometry of Cell Lysates
por: Rogawski, Rivkah, et al.
Publicado: (2021)

Prevalence of potential drug-drug interactions in Swedish pediatric outpatients
por: Holm, Johan, et al.
Publicado: (2019)

Intracellular drug binding affinities by NMR
por: Madl, Tobias
Publicado: (2021)

Challenges in Drug Discovery for Intracellular Bacteria
por: Tucker, Allison N., et al.
Publicado: (2021)

The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions
por: Pang, K. Sandy, et al.
Publicado: (2020)

Monitoring drug–target interactions through target engagement-mediated amplification on arrays and in situ
por: Al-Amin, Rasel A, et al.
Publicado: (2022)

Intracellular metabolism and effects of circulating cadmium-metallothionein in the kidney.
por: Squibb, K S, et al.
Publicado: (1984)

Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes
por: Fashe, Muluneh M., et al.
Publicado: (2022)

Effects of genetic polymorphism of drug-metabolizing enzymes on the plasma concentrations of antiepileptic drugs in Chinese population
por: Zhao, Weixuan, et al.
Publicado: (2022)

Intracellular metabolism of the orally active platinum drug JM216: influence of glutathione levels.
por: Raynaud, F. I., et al.
Publicado: (1996)

Evaluation of Parameters Impacting Drug Susceptibility in Intracellular Trypanosoma cruzi Assay Protocols
por: Yang, Gyongseon, et al.
Publicado: (2016)

Suppression of Sensitivity to Drugs and Antibiotics by High External Cation Concentrations in Fission Yeast
por: Alao, John P., et al.
Publicado: (2015)

Drug-drug interactions in polypharmacy patients: The impact of renal impairment
por: Papotti, Bianca, et al.
Publicado: (2021)

Intracellular Accumulation of Novel and Clinically Used TB Drugs Potentiates Intracellular Synergy
por: Tanner, Lloyd, et al.
Publicado: (2021)

High Throughput Screening of a Prescription Drug Library for Inhibitors of Organic Cation Transporter 3, OCT3
por: Chen, Eugene C., et al.
Publicado: (2022)

Staphylococcus aureus and Lipopolysaccharide Modulate Gene Expressions of Drug Transporters in Mouse Mammary Epithelial Cells Correlation to Inflammatory Biomarkers
por: Yagdiran, Yagmur, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hg2aceq8a19giase55jjfd6qcp